Showing results (251-260 of 266) with videos related to
Sort By:
Pageof 27
American Journal of Hematology|April 26, 2017
Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial)Najibah A Galadanci, Shehu Umar Abdullahi, Leah D Vance, et al.International Journal of Neonatal Screening|June 25, 2026
Implementation of a Prospective Birth Cohort for Newborn Screening and Early Linkage to Comprehensive Sickle Cell Disease Care in a Low-Resource SettingUmma A Ibrahim, Aisha B Musa, Oiza O Aliu-Isah, et al.Blood|March 12, 2025
A Controlled Trial for Preventing Priapism in Sickle Cell Anemia: Hydroxyurea plus Placebo vs Hydroxyurea plus TadalafilIbrahim Musa Idris, Aminu Abba Yusuf, Ismail Isah Ismail, et al.Plos One|May 5, 2012
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemiaJacqueline N Milton, Paola Sebastiani, Nadia Solovieff, et al.The Journal of Pediatrics|April 16, 2002
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial strokeDouglas J Scothorn, Cynthia Price, Daniel Schwartz, et al.Blood|March 17, 2024
An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell diseaseAdetola A Kassim, Josu de la Fuente, Erfan Nur, et al.Journal of Oncology Practice|July 12, 2017
Renal Medullary Carcinoma: Establishing Standards in PracticeKathryn E Beckermann, Deva Sharma, Shruti Chaturvedi, et al.Journal of Pediatric Hematology/Oncology|May 18, 2021
Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM FrameworkDjamila L Ghafuri, Shehu U Abdullahi, Abdu H Dambatta, et al.The Lancet. Haematology|December 31, 2021
Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trialShehu U Abdullahi, Binta W Jibir, Halima Bello-Manga, et al.Pediatric Blood & Cancer|March 7, 2025
Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU StudyAimee K Hildenbrand, Constance A Mara, Bridget Murphy, et al.Pageof 27